Literature DB >> 11803447

Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder.

C Betancur1, M Corbex, C Spielewoy, A Philippe, J L Laplanche, J M Launay, C Gillberg, M C Mouren-Siméoni, M Hamon, B Giros, M Nosten-Bertrand, M Leboyer.   

Abstract

Previous studies have provided conflicting evidence regarding the association of the serotonin transporter (5-HTT) gene with autism. Two polymorphisms have been identified in the human 5-HTT gene, a VNTR in intron 2 and a functional deletion/insertion in the promoter region (5-HTTLPR) with short and long variants. Positive associations of the 5-HTTLPR polymorphism with autism have been reported by two family-based studies, but one found preferential transmission of the short allele and the other of the long allele. Two subsequent studies failed to find evidence of transmission disequilibrium at the 5-HTTLPR locus. These conflicting results could be due to heterogeneity of clinical samples with regard to serotonin (5-HT) blood levels, which have been found to be elevated in some autistic subjects. Thus, we examined the association of the 5-HTTLPR and VNTR polymorphisms of the 5-HTT gene with autism, and we investigated the relationship between 5-HTT variants and whole-blood 5-HT. The transmission/disequilibrium test (TDT) revealed no linkage disequilibrium at either loci in a sample of 96 families comprising 43 trios and 53 sib pairs. Furthermore, no significant relationship between 5-HT blood levels and 5-HTT gene polymorphisms was found. Our results suggest that the 5-HTT gene is unlikely to play a major role as a susceptibility factor in autism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11803447      PMCID: PMC1896269          DOI: 10.1038/sj/mp/4000923

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  30 in total

1.  Evidence of linkage between the serotonin transporter and autistic disorder.

Authors:  E H Cook; R Courchesne; C Lord; N J Cox; S Yan; A Lincoln; R Haas; E Courchesne; B L Leventhal
Journal:  Mol Psychiatry       Date:  1997-05       Impact factor: 15.992

2.  Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.

Authors:  K P Lesch; D Bengel; A Heils; S Z Sabol; B D Greenberg; S Petri; J Benjamin; C R Müller; D H Hamer; D L Murphy
Journal:  Science       Date:  1996-11-29       Impact factor: 47.728

3.  Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium.

Authors:  E Maestrini; C Lai; A Marlow; N Matthews; S Wallace; A Bailey; E H Cook; D E Weeks; A P Monaco
Journal:  Am J Med Genet       Date:  1999-10-15

4.  Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets.

Authors:  B D Greenberg; T J Tolliver; S J Huang; Q Li; D Bengel; D L Murphy
Journal:  Am J Med Genet       Date:  1999-02-05

5.  Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study.

Authors:  A Philippe; M Martinez; M Guilloud-Bataille; C Gillberg; M Råstam; E Sponheim; M Coleman; M Zappella; H Aschauer; L Van Maldergem; C Penet; J Feingold; A Brice; M Leboyer; L van Malldergerme
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

6.  Effects of tryptophan depletion in drug-free adults with autistic disorder.

Authors:  C J McDougle; S T Naylor; D J Cohen; G K Aghajanian; G R Heninger; L H Price
Journal:  Arch Gen Psychiatry       Date:  1996-11

7.  A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

Authors:  C J McDougle; S T Naylor; D J Cohen; F R Volkmar; G R Heninger; L H Price
Journal:  Arch Gen Psychiatry       Date:  1996-11

8.  Serotonin transporter (5-HTT) gene variants associated with autism?

Authors:  S M Klauck; F Poustka; A Benner; K P Lesch; A Poustka
Journal:  Hum Mol Genet       Date:  1997-12       Impact factor: 6.150

9.  Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives.

Authors:  M Leboyer; A Philippe; M Bouvard; M Guilloud-Bataille; D Bondoux; F Tabuteau; J Feingold; M C Mouren-Simeoni; J M Launay
Journal:  Biol Psychiatry       Date:  1999-01-15       Impact factor: 13.382

Review 10.  Autism: the phenotype in relatives.

Authors:  A Bailey; S Palferman; L Heavey; A Le Couteur
Journal:  J Autism Dev Disord       Date:  1998-10
View more
  26 in total

1.  Support for the association between the rare functional variant I425V of the serotonin transporter gene and susceptibility to obsessive compulsive disorder.

Authors:  R Delorme; C Betancur; M Wagner; M O Krebs; P Gorwood; P Pearl; G Nygren; C M Durand; F Buhtz; P Pickering; J Melke; S Ruhrmann; H Anckarsäter; N Chabane; A Kipman; C Reck; B Millet; I Roy; M C Mouren-Simeoni; W Maier; M Råstam; C Gillberg; M Leboyer; T Bourgeron
Journal:  Mol Psychiatry       Date:  2005-12       Impact factor: 15.992

2.  Midline serotonergic neurones contribute to widespread synchronized activity in embryonic mouse hindbrain.

Authors:  Peter N Hunt; Annette K McCabe; Martha M Bosma
Journal:  J Physiol       Date:  2005-06-02       Impact factor: 5.182

3.  No gene is an island: the flip-flop phenomenon.

Authors:  Ping-I Lin; Jeffery M Vance; Margaret A Pericak-Vance; Eden R Martin
Journal:  Am J Hum Genet       Date:  2007-01-22       Impact factor: 11.025

Review 4.  Early pharmacological treatment of autism: a rationale for developmental treatment.

Authors:  Terrence C Bethea; Linmarie Sikich
Journal:  Biol Psychiatry       Date:  2007-02-15       Impact factor: 13.382

5.  Differential regulation of observational fear and neural oscillations by serotonin and dopamine in the mouse anterior cingulate cortex.

Authors:  Byung Sun Kim; Junghee Lee; Minji Bang; Bo Am Seo; Arshi Khalid; Min Whan Jung; Daejong Jeon
Journal:  Psychopharmacology (Berl)       Date:  2014-04-22       Impact factor: 4.530

6.  Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice.

Authors:  John J McMahon; Wilson Yu; Jun Yang; Haihua Feng; Meghan Helm; Elizabeth McMahon; Xinjun Zhu; Damian Shin; Yunfei Huang
Journal:  Neurobiol Dis       Date:  2014-10-12       Impact factor: 5.996

7.  Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.

Authors:  Richard Delorme; Catalina Betancur; Jacques Callebert; Nadia Chabane; Jean-Louis Laplanche; Marie-Christine Mouren-Simeoni; Jean-Marie Launay; Marion Leboyer
Journal:  Neuropsychopharmacology       Date:  2005-08       Impact factor: 7.853

Review 8.  Hyperserotoninemia and altered immunity in autism.

Authors:  Nancy K Burgess; Thayne L Sweeten; William M McMahon; Robert S Fujinami
Journal:  J Autism Dev Disord       Date:  2006-07

Review 9.  From loci to networks and back again: anomalies in the study of autism.

Authors:  Ralph-Axel Müller
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 10.  Identifying essential cell types and circuits in autism spectrum disorders.

Authors:  Susan E Maloney; Michael A Rieger; Joseph D Dougherty
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.